Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors

In vivo delivery of small molecule therapeutics to cancer cells, assessment of the selectivity of administration, and measuring the efficacity of the drug in question at the molecule level, are important ongoing challenges in developing new classes of cancer chemotherapeutics. One approach that has...

Descripción completa

Detalles Bibliográficos
Autores principales: Bofinger, Robin, Weitsman, Gregory, Evans, Rachel, Glaser, Matthias, Sander, Kerstin, Allan, Helen, Hochhauser, Daniel, Kalber, Tammy L., Årstad, Erik, Hailes, Helen C., Ng, Tony, Tabor, Alethea B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601123/
https://www.ncbi.nlm.nih.gov/pubmed/34730152
http://dx.doi.org/10.1039/d1nr02770k

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601123/
https://www.ncbi.nlm.nih.gov/pubmed/34730152
http://dx.doi.org/10.1039/d1nr02770k

Ejemplares similares